MFN Partners Management, LP Diversified Active

Location: Boston, MA

CIK: 0001732811 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 14, 2019

Total Value: $620M (100.0% shares, 0.0% debt)

Holdings (15)

— ALLERGAN PLC 15.4%

Value $95.18M Shares 650,101 Est. Cost $133.66 Unrealized —

FOXA FOX CORP 14.0%

Value $86.98M Shares 2,369,331 Est. Cost $35.41 Unrealized 0.0%

PCG PG&E CORP 11.5%

Value $71.2M Shares 4,000,000 Est. Cost $21.11 Unrealized -24.0%

IRWD IRONWOOD PHARMACEUTICALS INC 10.8%

Value $66.83M Shares 4,939,541 Est. Cost $11.48 Unrealized -2.7%

LNG CHENIERE ENERGY INC 8.3%

Value $51.27M Shares 750,000 Est. Cost $61.54 Unrealized +6.8%

BMY BRISTOL MYERS SQUIBB CO 7.7%

Value $47.71M Shares 1,000,000 Est. Cost — Unrealized —

XPO XPO LOGISTICS INC 7.3%

Value $45.44M Shares 845,500 Est. Cost $27.57 Unrealized -30.4%

— GTT COMMUNICATIONS INC 5.6%

Value $34.7M Shares 1,000,000 Est. Cost $23.66 Unrealized —

GS GOLDMAN SACHS GROUP INC 5.4%

Value $33.37M Shares 173,811 Est. Cost $170.89 Unrealized -3.9%

— PIONEER NAT RES CO 4.9%

Value $30.46M Shares 200,000 Est. Cost $131.52 Unrealized —

— FGL HLDGS 3.8%

Value $23.61M Shares 3,000,000 Est. Cost $7.72 Unrealized —

TAK TAKEDA PHARMACEUTICAL CO LTD 2.6%

Value $15.99M Shares 785,000 Est. Cost $20.37 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 1.4%

Value $8.985M Shares 1,500,000 Est. Cost $10.31 Unrealized -35.7%

NAVI NAVIENT CORPORATION 1.2%

Value $7.521M Shares 650,000 Est. Cost $11.45 Unrealized 0.0%

— REVANCE THERAPEUTICS INC 0.1%

Value $725K Shares 46,000 Est. Cost $20.13 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ALLERGAN PLC	650,101	$95.18M	15.4%	$133.66	—	SHS	G0177J108
FOXA	FOX CORP	2,369,331	$86.98M	14.0%	$35.41	0.0%	CL A COM	35137L105
PCG	PG&E CORP	4,000,000	$71.2M	11.5%	$21.11	-24.0%	COM	69331C108
IRWD	IRONWOOD PHARMACEUTICALS INC	4,939,541	$66.83M	10.8%	$11.48	-2.7%	COM CL A	46333X108
LNG	CHENIERE ENERGY INC	750,000	$51.27M	8.3%	$61.54	+6.8%	COM NEW	16411R208
BMY	BRISTOL MYERS SQUIBB CO	1,000,000	$47.71M	7.7%	—	—	Call	110122108
XPO	XPO LOGISTICS INC	845,500	$45.44M	7.3%	$27.57	-30.4%	COM	983793100
—	GTT COMMUNICATIONS INC	1,000,000	$34.7M	5.6%	$23.66	—	COM	362393100
GS	GOLDMAN SACHS GROUP INC	173,811	$33.37M	5.4%	$170.89	-3.9%	COM	38141G104
—	PIONEER NAT RES CO	200,000	$30.46M	4.9%	$131.52	—	COM	723787107
—	FGL HLDGS	3,000,000	$23.61M	3.8%	$7.72	—	ORD SHS	G3402M102
TAK	TAKEDA PHARMACEUTICAL CO LTD	785,000	$15.99M	2.6%	$20.37	—	SPONSORED ADS	874060205
ACRS	ACLARIS THERAPEUTICS INC	1,500,000	$8.985M	1.4%	$10.31	-35.7%	COM	00461U105
NAVI	NAVIENT CORPORATION	650,000	$7.521M	1.2%	$11.45	0.0%	COM	63938C108
—	REVANCE THERAPEUTICS INC	46,000	$725K	0.1%	$20.13	—	COM	761330109